Andere Sprachen Vincerx Pharma, Inc.

Aktien

A2QHQ0

US92731L1061

VINC

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 07.06.2024			% 5 Tage	% 1. Jan.
0,712 ^USD	-1,26 %		+12,84 %	-39,66 %

26.04.	Tech-Rallye beflügelt börsengehandelte Fonds und Aktienfutures vor dem Glockenschlag am Freitag	MT
26.04.	Vincerx Pharma preist öffentliches Angebot von Aktien und Optionsscheinen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update	14.05.
Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday	26.04.
Vincerx Pharma Prices Public Offering of Shares, Warrants	26.04.
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants	26.04.
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants	25.04.
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data	09.04.
Top Premarket Decliners	09.04.
Investors Eye Wednesday Inflation Data as US Futures Tread Water Tuesday Pre-Bell	09.04.
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024	08.04.
Vincerx Pharma, Inc. Presents Positive Preliminary Phase 1 Data for Vip236 and Updates on Pipeline Progress At the American Association for Cancer Research Annual Meeting 2024	08.04.
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024	01.04.
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update	29.03.
Vincerx Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
North American Morning Briefing : Tech in Focus on -2-	25.03.
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024	05.03.
Vincerx Pharma Shares Jump After Results of Blood Cancer Treatment Trial	08.01.
Top Premarket Gainers	08.01.
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma	07.01.
Vincerx Pharma, Inc. Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma	07.01.
Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023	10.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Vincerx Pharma, Inc.

Aktien

A2QHQ0

US92731L1061

VINC

Andere Sprachen

Filter